Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Oliver Wyman Health

Researchers were surprised by the variable that best predicted fatalities.

Charles Moskos Professor of Economics, Northwestern University
MUFG Bank Distinguished Professor of International Finance, Kellogg School of Management
Research Fellow, Freie Universität Berlin

Plus, Why We Should Still Be Thinking About Cumulative Population Immunity

Three takeaways from our analysis on possible Herd Immunity Threshold and how to reach it together.

Partner, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

With the pandemic accelerating transformation, AMC strategies must reimagine their operations to deliver new value.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Supporting leaders in pursuit of health transformation, Oliver Wyman joined forces with venture capitalist firms on a new mentorship program.

Considerations for Consumers, Providers, and Payers

The concept of “healthcare delivery” is dramatically shifting and opportunities for stakeholders abound.

VP of Client Delivery, Quil

Insights in your inbox

Subscribe

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

Lessons Learned and Future Visions

Humana shares its ongoing journey to make communities healthier through a personalized care approach.

VP, Bold Goal and Population Health Strategy, Humana
Partner, Health and Life Sciences, Oliver Wyman

Five Healthtech Predictions to Expect Next

Humanizing AI in healthtech will redefine what care delivery and patient-physician engagement look like.

Personalized, Proactive, and Smarter Care

AI's capability to detect medical conditions early and accurately will disrupt traditional business models.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Why Biology Is No Longer Destiny (Or Maybe It Never Was)

Innovations like CRISPR that once seemed more like science fiction are becoming reality. And the business of care delivery is shifting as a result.

Insights in your inbox

Subscribe